ONECLICK WRITE TO THE MRC ABOUT BIOLOGICAL RESEARCH INTO ME/CFS Angela Kennedy, Director of The One Click Group, has written to Colin Blakemore, ------------------------------------------------------------------------ Professor Colin Blakemore Chief Executive Medical Research Council 20 Park Crescent London W1B 1AL 20th May 2004 Dear Professor Blakemore, MRC FUNDING FOR RESEARCH INTO ME/CFS I am writing to you as the mother and carer of a young woman seriously ill with and severely disabled by Myalgic Encephalomyelitis (also known as Chronic Fatigue Syndrome). I am aware that the Department of Health have asked the Medical Research Council to develop a research strategy with regard to this serious illness. The MRC (according to your website): ".promotes a balanced portfolio of medical and related biological research aimed at: * improving our knowledge of the underlying basis of health and disease and * delivering enhanced prevention, diagnosis and treatment of human disorders." As you will be aware, there have been many legitimate and serious concerns expressed by members of the ME community, including some of the charities, about the serious lack of research into the organic (or biological) aetiology of ME/CFS in Britain, linked to a lack of funding, including that by government. Many members of the ME/CFS community and their supporters are also concerned that a disproportionate amount of funding is meanwhile being devoted and is likely to be devoted to researching ME/CFS from a psychiatric perspective, which has itself been severely criticised from various methodological and theoretical perspectives, both in the UK and internationally. In your recent letter in the Independent, you stated that the MRC ".have actively encouraged the submission of other proposals for CFS/ME - from biological research to treatment studies. We are currently reviewing a number of applications." I am aware of the 'holistic' approach to health taken by many of the UK health services. However, with the above issues in mind, I would be grateful if you would provide answers to the following questions: 1. How many applications for exclusively biological research into the aetiology of ME/CFS are currently under review at the MRC? 2. How many applications for bio-medical (but as opposed to 'bio-psychosocial') research, including 'treatment studies', are currently under review at the MRC? 3. How many applications for research with any psychiatric, 'psycho-social' or psychological context are currently under review at the MRC (apart from the PACE and FINE trials)? 4. When will decisions be made for funding of any of the applications under review? 5. How will such decisions (acceptances or rejections) be made available to interested parties, such as the ME charities, and ME sufferers and advocates themselves? 6. What are the details of all project applications currently under review at the MRC? I am sure the critical importance of the above issues and their ramifications for ME/CFS sufferers and their supporters will not be lost on you. I would therefore be grateful for your response to these questions as a matter of urgency. Yours faithfully, Angela Kennedy